论文部分内容阅读
目的:分析比较胺碘酮联合利多卡因用于急性心肌梗死后室性心律失常的临床价值与效果。方法:选取60例急性心肌梗死后室性心律失常患者作为研究对象,随机分为观察组(30例,胺碘酮联合利多卡因治疗)和对照组(30例,利多卡因治疗)。连续治疗24周后,观察两组症状体征改善情况以及不良反应的发生率。结果:观察组总有效率优于对照组(P<0.05),差异显著;观察组患者在治疗时,心律失常、胃肠道反应以及静脉炎等不良反应发生率低于对照组(P<0.05),差异显著。结论:胺碘酮联合利多卡因用于治疗急性心肌梗死后室性心律失常疗效显著,具有较高的临床使用价值。
Objective: To analyze the clinical value and effect of amiodarone combined with lidocaine for ventricular arrhythmia after acute myocardial infarction. Methods: Sixty patients with ventricular arrhythmia after acute myocardial infarction were randomly divided into observation group (30 cases, amiodarone combined lidocaine treatment) and control group (30 cases, lidocaine treatment). After continuous treatment for 24 weeks, two groups were observed the improvement of symptoms and signs and the incidence of adverse reactions. Results: The total effective rate in the observation group was significantly higher than that in the control group (P <0.05), and the difference was significant. In the observation group, the incidence of adverse reactions such as arrhythmia, gastrointestinal reaction and phlebitis were lower than those in the control group ),Significant difference. Conclusion: Amiodarone combined with lidocaine is effective in treating ventricular arrhythmia after acute myocardial infarction and has high clinical value.